Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

51.54
Delayed Data
As of Aug 28
 -0.02 / -0.04%
Today’s Change
35.26
Today|||52-Week Range
77.80
-16.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-84.8M-65.5M-60.6M-39.0M
 
 
 
 
 
Depreciation11.8M10.8M9.8M9.4M
 
 
 
 
 
Total Other Cash Flow25.6M6.4M28.3M30.7M
 
 
 
 
 
Funds From Operations-47.4M-48.3M-22.5M1.1M
 
 
 
 
 
Funds From/For Other Operating Expenses67.4M-50.2M-86.0M-5.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-114.8M1.9M63.5M6.3M
 
 
 
 
 
 
InvestingIncrease In Investments-371.5M-221.7M-425.6M-391.9M
 
 
 
 
 
Decrease In Investments493.4M244.8M175.2M320.1M
 
 
 
 
 
Capital Expenditures-7.3M-1.5M-1.6M-7.5M
 
 
 
 
 
Net Cash Flow Investing110.9M18.0M-255.7M-82.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings--194.7M0.00487.0M
 
 
 
Long Term Debt Reduction-5.9M-174.1M-11.0M-452.0M
 
 
 
 
 
Net Proceeds Stock Sale3.6M9.5M236.3M23.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.6M9.1M2.5M1.5M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-672.0K39.1M227.7M59.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-4.6M59.0M35.5M-17.0M